m-Benzoylhydratropic acid en es it fr

m-Benzoylhydratropic acid Brand names, m-Benzoylhydratropic acid Analogs

m-Benzoylhydratropic acid Brand Names Mixture

  • Anivy (Benzocaine + Chlorphenesin + Titanium Dioxide + Zinc Oxide)

m-Benzoylhydratropic acid Chemical_Formula

C26H40O5

m-Benzoylhydratropic acid RX_link

http://www.rxlist.com/cgi/generic/latanoprost.htm

m-Benzoylhydratropic acid fda sheet

m-Benzoylhydratropic_acid FDA

m-Benzoylhydratropic acid msds (material safety sheet)

m-Benzoylhydratropic_acid MSDS

m-Benzoylhydratropic acid Synthesis Reference

No information avaliable

m-Benzoylhydratropic acid Molecular Weight

432.593 g/mol

m-Benzoylhydratropic acid Melting Point

No information avaliable

m-Benzoylhydratropic acid H2O Solubility

8 mg/mL

m-Benzoylhydratropic acid State

Liquid

m-Benzoylhydratropic acid LogP

4.027

m-Benzoylhydratropic acid Dosage Forms

Solution

m-Benzoylhydratropic acid Indication

For the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.

m-Benzoylhydratropic acid Pharmacology

Latanoprost is an isopropyl ester prodrug which is inactive but which becomes active after hydrolysis to the acid from. Latanoprost opthalmic solution is a topical medication used for controlling the progression of glaucoma or ocular hypertension, by reducing intraocular pressure. It is a prostaglandin analogue that works by increasing the outflow of aqueous fluid from the eyes.

m-Benzoylhydratropic acid Absorption

Latanoprost is well absorbed through the cornea where the isopropyl ester prodrug is hydrolyzed to the acid form. Peak concentration is reached 2 hrs after topical administration.

m-Benzoylhydratropic acid side effects and Toxicity

Symptoms of overdose include bloodshot eyes and eye irritation.

m-Benzoylhydratropic acid Patient Information

http://www.drugs.com/MTM/lactulose.html

m-Benzoylhydratropic acid Organisms Affected

Humans and other mammals